Nasal spray bottle convenient for administration
By designing a nasal spray bottle that can control the spray angle and dual-cavity structure of the medicine liquid, it solves the inconvenience and hygiene problems of traditional nasal spray administration, improves the accuracy and safety of the drug administration, and is suitable for middle-aged and elderly people. Demand for medication alone.
Patent Information
- Application Number
- CN202323435760.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-18
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2033-12-18
AI Technical Summary
The administration of traditional nasal sprays is inconvenient, especially for middle-aged and elderly people who are given medicine alone, which can easily cause inaccurate spraying of medicines, contamination and hygiene problems, and there is a risk of nosebleeds and irritation reactions.
A nasal spray bottle was designed, which contains a drug delivery structure that can control the spray angle of the drug liquid and a cleanable protective layer. It adopts a dual-cavity structure and a liquid-polymer structure, which increases the accuracy and hygiene of the drug delivery, and through The unique shape and colliding color of the raised press pad and press ball are convenient for patient operation.
The drug administration operation is simplified, the precise application of the drug solution to the outer wall of the nasal cavity is improved, the waste is reduced, and the safety and hygiene of the drug administration is enhanced. It is suitable for the solitary drug administration scenarios of middle-aged and elderly patients.
Smart Images

Figure CN221950432U_ABST
Abstract
Description
Technical Field
[0001] The utility model belongs to the structural field of nasal spray bottles, and in particular relates to a nasal spray bottle which is convenient for drug administration. Background Art
[0002] The respiratory tract is the main area where the human body comes into contact with the outside world. It is the entrance for bacteria and viruses, and it also has potential value for drug development. Nasal sprays were initially used to treat local symptoms of rhinitis and respiratory infectious diseases, and were later gradually developed to treat various systemic diseases, such as cardiovascular disease and neurological diseases. Compared with traditional oral administration, inhalation of nasal sprays can directly reach the venous circulation of the head and neck without first-pass metabolism. Compared with oral medications, it has the advantages of faster onset and less dosage; compared with intravenous injections, it has the advantages of reduced acupuncture risks and high patient satisfaction.
[0003] There is a "blood-brain barrier" between the brain and the blood, which can block most drug ingredients from entering the brain. The upper part of the nasal cavity is covered with nerve endings and has olfactory mucosa that can feedback olfactory information to the brain. When the drug comes into contact with the olfactory mucosa, it can be quickly transported along the nerve fibers to the brain and cerebrospinal fluid, which is called the "nose-brain pathway". Therefore, some central acting drugs such as analgesics, sedatives and anti-epileptic drugs can also be administered through nasal sprays.
[0004] However, there are also some disadvantages to nasal administration. In addition to the risk of side effects of certain drugs, due to the particularity of the drug delivery device, the drug needs to be delivered in a specific way. Because the nasal septum inside the nasal cavity is very weak in impact resistance, if the drug is sprayed on the nasal septum due to operational errors, it will usually cause nose bleeding, which will hinder drug delivery and affect the treatment of the disease; and there are certain requirements for the angle of drug delivery. If a certain angle is not maintained during the drug delivery process, the drug will directly impact the nasopharynx and cause irritation, which will affect the drug delivery and cause psychological trauma and usage burden to the patient, which is not conducive to subsequent drug delivery treatment.
[0005] The existing public administration method is to point the nozzle toward the outer corner of the eye and keep the bottle vertical without tilting. Because some drugs are irritating, patients with nasal sensitivity usually experience edema, sneezing, nasal itching, nasal congestion and other reactions when taking the drug. If the drug needs to be taken strictly in a specific way at this time, it will cause greater psychological pressure on the patient, which is not conducive to the treatment of the disease.
[0006] When using traditional nasal sprays for medication, it is usually necessary to strictly control the medication angle so that the drug solution acts on the outer wall of the nasal cavity. However, when administering the drug alone, due to the limitations of the use environment, it is not always possible to use a mirror to correct the medication angle. This makes some patients, in order to facilitate medication, often place the mouth of the nasal spray bottle next to the outer wall of the nasal cavity for medication. Such an operation is prone to contamination and is not conducive to long-term medication. According to incomplete statistics, when middle-aged and elderly patients use traditional nasal sprays, more than half of them will have a certain resistance when using them alone due to the special requirements of the medication method. Some of these patients will cause the aforementioned medication problems due to incorrect administration methods, causing a usage burden and affecting medication compliance.
[0007] It can be seen that the administration operation of traditional nasal sprays is inconvenient in actual use, especially for middle-aged and elderly people who administer the medicine alone. Therefore, it is very necessary to design a new nasal spray structure combined with a simple administration method to improve the current situation. Utility Model Content
[0008] In response to the above problems, the inventors discovered during their research on the structure of the nasal cavity that, among the three main parts constituting the nasal cavity, the nasal septum is very fragile and cannot withstand the administration of liquids; the nasopharynx, due to its own irritation, requires strict control of the angle of administration to prevent the entry of the drug solution, but the outer wall of the nasal cavity does not have the above problems and is a good drug administration part. Conventional nasal sprays are often administered at the front end of the nostrils, spraying the drug solution directly onto the outer wall of the nasal cavity. However, in the prior art, many patients usually place the front end of the drug bottle close to one side of the nasal cavity for administration due to environmental factors. Although this is convenient to operate, it poses a major challenge to the hygiene and safety of the preparation.
[0009] In view of the above situation, the inventor has developed a drug delivery structure that can control the spray angle of the drug solution into the nasal cavity, and in view of the hygienic factors of drug delivery, a washable protective layer is used. In addition, the drug delivery structure of the utility model also has a double-cavity structure for compound drug delivery.
[0010] In order to achieve the above purpose, the utility model adopts the following technical solutions:
[0011] A nasal spray bottle comprises a bottle cap (22) and a bottle body (4), wherein the bottle cap (22) has a bottle body docking portion (23); the bottle body (4) is composed of two parts, which are, from top to bottom: a drug dispenser (1) and a temporary drug storage area (5) therein, and a liquid storage portion (6), wherein the temporary drug storage area (5) and the liquid storage portion (6) are separated by a drug separation plate (9).
[0012] The upper part of the bottle body (4) is provided with a connection point (11) between the drug delivery device protective layer and the bottle cap. When administering the drug, the bottle cap (22) must be removed first and then the drug delivery device protective layer (10) must be clamped on the connection point (11) between the drug delivery device protective layer and the bottle cap. After the drug delivery into the nasal cavity is completed, the drug delivery device protective layer (10) must be removed for washing and disinfection and placed aside for recycling. Thereafter, the bottle cap (22) must be clamped on the connection point (11) between the drug delivery device protective layer and the bottle cap on the bottle body (4) and placed aside for next use.
[0013] The bottle cap (22) and the drug delivery device protective layer (10) can both be clamped on the connection (11) between the drug delivery device protective layer and the bottle cap through the structure of the connection (11) between the drug delivery device protective layer and the bottle cap.
[0014] In some embodiments, a liquid collecting structure (3) is provided at the bottom of the liquid storage portion (6). The liquid collecting structure (3) has an inclination angle, and a drug liquid passage 1 (31) or a drug liquid passage 2 (32) is provided at the upper part of the lowest point of the inclination angle. The function of the liquid collecting structure (3) is to better absorb the drug liquid when administering the drug.
[0015] In some embodiments, the outer wall of the liquid storage part (6) is provided with a raised pressing pad (25) and a pressing ball (26) embedded in the raised pressing pad (25), so that during the drug administration process, the drug liquid located in the liquid storage part (6) can be squeezed into the drug liquid temporary storage area (5) through the liquid outlet 1 (51) of the drug liquid passage 1 (31) or the liquid outlet 2 (52) of the drug liquid passage 2 (32) and then acts on the outer wall of the nasal cavity through the drug liquid nozzle (41) of the drug delivery device and the drug liquid nozzle (42) of the protective layer of the drug delivery device.
[0016] In some embodiments, the liquid storage part (6) can be further divided into liquid storage area 1 (61) and liquid storage area 2 (62), separated by a liquid storage area drug liquid partition (65) in the liquid storage part (6).
[0017] In some embodiments, separate liquid collecting structures (3) are respectively provided at the bottom of the liquid storage area 1 (61) and the bottom of the liquid storage area 2 (62).
[0018] In some embodiments, the liquid partition plate (9) between the liquid temporary storage area (5) and the liquid storage area (6) is provided with a liquid outlet 1 (51) and a liquid outlet 2 (52) corresponding to the liquid storage area 1 (61) and the liquid storage area 2 (62).
[0019] In some embodiments, the drug liquid nozzle (41) of the applicator (1) and the drug liquid nozzle (42) of the applicator protective layer (10) are circular.
[0020] In some embodiments, the diameter of the drug liquid nozzle (41) of the applicator (1) is larger than the diameter of the drug liquid nozzle of the applicator protective layer (10) of the applicator.
[0021] In some embodiments, the applicator (1) is a semi-cylinder.
[0022] In some embodiments, the applicator protective layer (10) is a semi-cylinder.
[0023] In some embodiments, the bottle cap (22) is a semi-cylinder.
[0024] In some embodiments, the raised pressing pad (25) is a pentagonal structure; and the pressing ball (26) is a multi-striped structure.
[0025] In some embodiments, the raised pressing pad (25) and the pressing ball (26) are in striking contrasting colors.
[0026] The utility model has the following beneficial effects.
[0027] 1. This product improves the administration method of traditional nasal spray bottles, avoids complicated operations, and makes it easier for patients to administer the medicine themselves.
[0028] 2. This product improves the structure of the traditional nasal spray bottle and adds a semi-cylindrical drug delivery part, which can penetrate deep into the nasal cavity and adhere to the internal structure of the nasal cavity. While avoiding drug delivery stimulation, the drug solution can be accurately applied to the outer wall of the nasal cavity.
[0029] 3. This product overcomes the hygiene problems caused by traditional drug delivery methods by improving the structure of traditional nasal spray bottles and adopting a detachable and flushable drug delivery device protective layer.
[0030] 4. This product improves the structure of the traditional nasal spray bottle and has a liquid gathering structure at the bottom of the bottle, which can effectively reduce waste.
[0031] 5. This product improves the structure of the traditional nasal spray bottle. There are two liquid storage areas inside the bottle. The liquid storage areas can be used individually or in combination, which increases the usage scenarios of the nasal spray bottle.
[0032] 6. This product improves the structure of the traditional nasal spray bottle. The raised pressing pad (25) and the pressing ball (26) adopt a unique shape and conspicuous contrasting colors, which makes it easier for middle-aged and elderly patients to accurately grasp the pressing position when using it. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Attached Figure 1 A front view of a nasal spray bottle.
[0034] Attached Figure 2 This is a front view of the nasal spray bottle (dosing state).
[0035] Attached Figure 3 A side view of a nasal spray bottle.
[0036] Attached Figure 4 It is a front view of the cap of the nasal spray bottle.
[0037] Attached Figure 5 A top view of a nasal spray bottle.
[0038] In the figure: 1-dose dispenser; 2-drug solution spraying path; 3-liquid gathering structure; 4-bottle body; 5-drug solution temporary storage area; 6-liquid storage part; 9-drug solution partition plate; 10-dose dispenser protective layer; 11-connection between the drug dispenser protective layer and the bottle cap; 22-bottle cap; 23-bottleneck connection of the bottle body; 25-raised pressing pad; 26-pressing ball; 31-drug solution passage 1; 32-drug solution passage 2; 41-drug solution nozzle of the drug dispenser; 42-drug solution nozzle of the drug dispenser protective layer; 51-liquid outlet 1; 52-liquid outlet 2; 61-liquid storage area 1; 62-liquid storage area 2; 65-liquid solution partition of the liquid storage area. DETAILED DESCRIPTION
[0039] The preferred embodiments of the present invention are described below with reference to the accompanying drawings. It should be understood by those skilled in the art that these embodiments are only used to explain the technical principles of the present invention and are not intended to limit the protection scope of the present invention.
[0040] Example 1
[0041] like Figure 1-5 The present invention shows a nasal spray bottle, comprising a bottle cap (22) and a bottle body (4); the bottle cap (22) is semi-cylindrical, and a bottle body docking point (23) is provided at the bottom of the bottle cap (22); the bottle body (4) is composed of two parts, which are, from top to bottom, a drug delivery device (1) and a temporary drug storage area (5) therein, and a liquid storage area (6); wherein the temporary drug storage area (5) and the liquid storage area (6) are separated by a drug separation plate (9).
[0042] The drug dispensing device (1) is semi-cylindrical in shape, wherein 3-5 drug dispensing device drug liquid nozzles (41) are provided on one side of the arc surface.
[0043] The outer side of the applicator (1) can be connected to a applicator protective layer (10). The applicator protective layer (10) is semi-cylindrical in shape. One side of the arc surface is provided with applicator protective layer liquid medicine nozzles (42) whose number is the same as the liquid medicine nozzles of the applicator (1). The applicator protective layer (10) is connected to the liquid storage portion (6) of the bottle body through a connection portion (11) between the applicator protective layer and the bottle cap located on the bottle body (4).
[0044] The connection point (11) between the applicator protective layer and the bottle cap on the bottle body (4) can be connected to the applicator protective layer (10) and can also be connected to the bottle cap (22) through the bottle body docking point (23) at the bottom of the bottle cap. However, the applicator protective layer (10) and the bottle cap (22) cannot be connected at the same time.
[0045] When the nasal spray bottle is stored at rest, there is no need to install the applicator protective layer (10); when administering the drug, the bottle cap (22) needs to be removed first, and then the applicator protective layer (10) needs to be connected to the bottle body.
[0046] The liquid storage area (6) of the bottle body (4) can be divided into a liquid storage area 1 (61) and a liquid storage area 2 (62) by a liquid storage area partition (65), thereby providing a wider applicable environment for preparations.
[0047] An independent liquid collecting structure (3) is provided at the bottom of the liquid storage area 1 (61) and the liquid storage area 2 (62). The liquid collecting structure (3) has an inclined angle, and a drug liquid passage 1 (31) and a drug liquid passage 2 (32) are provided at the upper part of the lowest part of the liquid collecting structure (3).
[0048] The liquid medicine partition plate (9) is provided with liquid outlets corresponding to the number of liquid storage areas, specifically, liquid outlet 1 (51) and liquid outlet 2 (52). The liquid medicine in the liquid storage area 1 (61) and the liquid storage area 2 (62) passes through the liquid medicine passage 1 (31) and the liquid medicine passage 2 (32), and then passes through the liquid outlet 1 (51) and the liquid outlet 2 (52) to reach the liquid medicine temporary storage area (5) in the drug dispenser (1), and then is applied to the outer wall of the nasal cavity through the drug medicine nozzle (41) of the drug dispenser and the drug medicine nozzle (42) of the protective layer of the drug dispenser.
[0049] The outer wall of the liquid storage portion (6) is provided with a raised pressing pad (25), and a pressing ball (26) is provided inside the raised pressing pad (25), which is provided in contrasting colors such as yellow and purple, red and turquoise.
[0050] Example 2 (single liquid storage area)
[0051] When administering the drug, the bottle cap (22) must first be removed from the connection point (11) between the drug delivery device protective layer and the bottle cap, and then the drug delivery device protective layer (10) must be installed at the connection point (11) between the drug delivery device protective layer and the bottle cap.
[0052] Then, the applicator (1) with the applicator protective layer (10) is inserted into the nasal cavity. When entering, the arc surface of the semi-cylinder needs to be aligned with the outside of the nasal cavity. The flat part of the semi-cylinder can be inserted along the nasal septum.
[0053] Afterwards, the raised pressing pad (25) on the liquid storage part (6) is pressed, and under the action of the liquid collecting structure (3) at the bottom of the liquid storage part (6), the liquid medicine will pass through the liquid medicine passage and the liquid outlet, enter the liquid medicine temporary storage area (5), and then be applied to the outer wall of the nasal cavity through the liquid medicine nozzle (41) of the applicator and the liquid medicine nozzle (42) of the protective layer of the applicator.
[0054] After the administration is completed, the protective layer (10) of the drug delivery device is removed from the connection between the protective layer of the drug delivery device and the bottle cap (11), rinsed, disinfected, and placed aside for storage. Thereafter, the bottle cap (22) is installed onto the connection between the protective layer of the drug delivery device and the bottle cap (11), and the nasal spray is placed aside for the next administration.
[0055] Example 3 (Dual Liquid Storage Areas)
[0056] When administering the drug, the bottle cap (22) must first be removed from the connection point (11) between the drug delivery device protective layer and the bottle cap, and then the drug delivery device protective layer (10) must be installed at the connection point (11) between the drug delivery device protective layer and the bottle cap.
[0057] Then, the applicator (1) with the applicator protective layer (10) is inserted into the nasal cavity. When entering, the arc surface of the semi-cylinder needs to be aligned with the outside of the nasal cavity, and the flat side of the semi-cylinder needs to be inserted along the nasal septum without strictly controlling the angle.
[0058] Afterwards, the raised pressing pad (25) on the liquid storage part (6) is pressed, and under the action of the liquid collecting structure (3) in the liquid storage area 1 (61) and the liquid storage area 2 (62), the liquid medicine will pass through the liquid medicine passage 1 (31) and the liquid medicine passage 2 (32), the liquid outlet 1 (51) and the liquid outlet 2 (52), enter the liquid medicine temporary storage area (5), and then be applied to the outer wall of the nasal cavity through the liquid medicine nozzle (41) of the applicator and the liquid medicine nozzle (42) of the protective layer of the applicator.
[0059] After the administration is completed, the protective layer (10) of the drug delivery device is removed from the connection between the protective layer of the drug delivery device and the bottle cap (11), rinsed, disinfected, and placed aside for storage. Thereafter, the bottle cap (22) is installed onto the connection between the protective layer of the drug delivery device and the bottle cap (11), and the nasal spray is placed aside for the next administration.
[0060] It should be noted that in the description of the present invention, the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer" and the like indicating directions or positional relationships are based on the directions or positional relationships shown in the drawings, which are only for the convenience of description, and do not indicate or imply that the device or element must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as limiting the present invention. In addition, the terms "first", "second", and "third" are used for descriptive purposes only, and cannot be understood as indicating or implying relative importance.
[0061] In addition, it should be noted that in the description of the present invention, unless otherwise clearly specified and limited, the terms "installation", "connection" and "connection" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal communication of two components. For those skilled in the art, the specific meanings of the above terms in the present invention can be understood according to the specific circumstances.
[0062] The term "comprise" or any other similar term is intended to cover a non-exclusive inclusion, such that a process, article, or apparatus / device that includes a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such process, article, or apparatus / device.
[0063] So far, the technical solution of the present invention has been described in conjunction with the preferred embodiments shown in the accompanying drawings. However, it is easy for those skilled in the art to understand that the protection scope of the present invention is obviously not limited to these specific embodiments. Without departing from the principle of the present invention, those skilled in the art can make equivalent changes or substitutions to the relevant technical features, and the technical solutions after these changes or substitutions will fall within the protection scope of the present invention.
Claims
1. A nasal spray bottle, comprising a bottle cap (22) and a bottle body (4), characterized in that: A. The bottle body (4) is composed of two parts, which are, from top to bottom, respectively: a drug dispenser (1) and a drug liquid temporary storage area (5) therein, and a liquid storage area (6), wherein the drug liquid temporary storage area (5) and the liquid storage area (6) are separated by a drug liquid partition plate (9); B. The outside of the drug delivery device (1) is provided with a drug delivery device protection layer (10); C. The upper portion of the liquid storage portion (6) is provided with a connection portion (11) between the applicator protective layer and the bottle cap that can be connected to the applicator protective layer (10) and the bottle cap (22); D. A liquid collecting structure (3) is provided at the bottom of the liquid storage part (6).
2. A nasal spray bottle according to claim 1, characterized in that: The applicator (1), the applicator protective layer (10), and the bottle cap (22) are semi-cylindrical structures.
3. A nasal spray bottle according to claim 1, characterized in that: The liquid collecting structure (3) at the bottom of the liquid storage part (6) has an inclination angle, and the drug liquid passage 1 (31) or the drug liquid passage 2 (32) exists at the upper part of the lowest point of the inclination angle.
4. A nasal spray bottle according to claim 1, characterized in that: The outer wall of the liquid storage portion (6) is provided with a protruding pressing pad (25) and a pressing ball (26) embedded in the protruding pressing pad (25).
5. A nasal spray bottle according to claim 1, characterized in that: The liquid storage area (6) can be divided into a liquid storage area 1 (61) and a liquid storage area 2 (62) by a liquid storage area liquid partition (65).
6. A nasal spray bottle according to claim 5, wherein the liquid storage portion (6) is further divided into a liquid storage area 1 (61) and a liquid storage area 2 (62), characterized in that: A separate liquid collecting structure (3) is provided at the bottom of each of the liquid storage area 1 (61) and the liquid storage area 2 (62).
7. A nasal spray bottle according to any one of the preceding claims, characterized in that: A liquid outlet 1 (51) and a liquid outlet 2 (52) corresponding to the liquid storage area 1 (61) and the liquid storage area 2 (62) are provided on the liquid partition plate (9) between the liquid temporary storage area (5) and the liquid storage area (6).
8. A nasal spray bottle according to any one of the preceding claims, characterized in that: The applicator (1) has a drug liquid spraying port (41) which is circular; the applicator protective layer drug liquid spraying port (42) is provided on the applicator protective layer (10) and the drug liquid spraying port (42) is circular.
9. A nasal spray bottle according to any one of the preceding claims, characterized in that: The diameter of the drug liquid nozzle (41) of the drug dispenser (1) is larger than the diameter of the drug liquid nozzle of the drug dispenser protective layer (10) of the drug dispenser.
10. A nasal spray bottle according to any one of the preceding claims, characterized in that: The raised pressing pad (25) and the pressing ball (26) are in contrasting colors.
